Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kota Yokosu
Observed names:
K. Yokosu,
KOTA YOKOSU,
Yokosu Kota
Institutions:
Jikei University School of Medicine,
National Cancer Center Hospital East
Observed institutions:
Jikei University School of Medicine,
Jikei University Kashiwa hospital,
National Cancer Center Hospital East
ORCID:
0000-0002-1203-8167
Observed ORCID:
0000-0002-1203-8167
OpenAlex ID:
A5027361689
Total parietal peritonectomy in primary debulking surgery for advanced ovarian cancer
2021
·
Kota Yokosu
, Hiroshi Tanabe
, et al.
·
Gynecologic Oncology Reports
·
10
PDF
MR Relaxometry for Discriminating Malignant Ovarian Cystic Tumors: A Prospective Multicenter Cohort Study
2024
·
Naoki Kawahara
, Hiroshi Kobayashi
, et al.
·
Diagnostics
·
3
Short- and long-term morbidity of total parietal peritonectomy for advanced ovarian cancer
2023
·
Suguru Odajima
, Hiroshi Tanabe
, et al.
·
International Journal of Gynecological Cancer
·
3
Diagnostic performance of artificial intelligence for detecting peritoneal and small bowel dissemination in epithelial ovarian cancer using preoperative contrast-enhanced CT imaging
2026
·
Ria Kim
, Toshiyuki Seki
, et al.
·
Scientific Reports
·
1
PDF
Lower abdominal pain in an elderly female: Pelvic congestive syndrome
2025
·
Takae Ebihara
, Kota Yokosu
, et al.
·
Geriatrics and gerontology international/Geriatrics & gerontology international
·
1
Thoracic recurrence after complete gross resection in advanced ovarian cancer: The clinical impact of occult subdiaphragmatic lymphatic invasion
2026
·
Junki Onishi
, Michiko Nagamine
, et al.
·
Gynecologic Oncology
Real-world Safety and Efficacy of Niraparib Maintenance Therapy in Japanese Patients With Platinum-sensitive Recurrent Ovarian Cancer: Jgog3031 Cohort 1
2026
·
Satoe Fujiwara
, Shimada Muneaki
, et al.
·
International Journal of Gynecological Cancer
Changes and clinical impact of HER3 and ERBB3 expression in primary and recurrent ovarian cancer
2026
·
Kota Yokosu
, Riu Yamashita
, et al.
·
Journal of Gynecologic Oncology
PDF
155P Safety and efficacy of niraparib in Japanese recurrent ovarian cancer patients: Maintenance therapy for platinum-sensitive recurrence and late-line monotherapy
2026
·
S. Fujiwara
, M. Shimada
, et al.
·
ESMO Open
PDF
618P The automatic diagnosis artificial intelligence system for preoperative computed tomography assessment of peritoneal dissemination in ovarian cancer
2025
·
R. Kim
, T. Seki
, et al.
·
Annals of Oncology
Therapeutic effect of dose-dense paclitaxel plus carboplatin with or without bevacizumab for Japanese patients with epithelial ovarian cancer
2024
·
Yuki Kochi
, Satoshi Hosoya
, et al.
·
International Journal of Clinical Oncology
74 Clinical impact of HER3/ERBB3 expression in primary and recurrent ovarian cancer
2024
·
Kota Yokosu
, Kenichi Harano
, et al.
·
International Journal of Gynecological Cancer
EP275/#524 Retrospective analysis of total parietal peritonectomy without systematic lymphadenectomy for advanced epithelial ovarian cancer
2022
·
Suguru Odajima
, Hiroshi Tanabe
, et al.
·
International Journal of Gynecological Cancer
PDF
EP307/#659 The long-term prognosis of total parietal peritonectomy in primary debulking surgery for advanced ovarian cancer
2022
·
Kota Yokosu
, Hiroshi Tanabe
, et al.
·
International Journal of Gynecological Cancer
PDF
Retrospective Analysis of Total Parietal Peritonectomy Without Systematic Lymphadenectomy for Advanced Epithelial Ovarian Cancer
2022
·
SUGURU ODAJIMA
, HIROSHI TANABE
, et al.
·
Cancer Diagnosis & Prognosis
一から学びなおす 婦人科がん化学療法有害事象の管理 15.治療関連骨髄性腫瘍(二次性白血病・骨髄異形成症候群)
2020
·
Yokosu Kota
, Tanabe Hiroshi
·
産科と婦人科
Show more works
View as search
Works count:
16
Citation count:
18
H-index:
3
I10-index:
1
Year
Topic
Type